Radiofrequency ablation of haemodynamically unstable ventricular tachycardia after myocardial infarction

Heart

Volumn 84, Issue 6, 2000, Pages 648-652

  Furniss, S ^a   Anil Kumar, R ^a   Bourke, J P ^a   Behulova, R ^a   Simeonidou, E ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Catheter ablation; Sudden death; Tachycardia

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; MALE; PRIORITY JOURNAL; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0033658954     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.6.648     Document Type: Article

References (28)

1. Ablative therapy for ventricular arrhythmias
2. Insights into the electrophysiology of ventricular-tachycardia gained by the catheter ablation experience - Learning while burning
3. Catheter ablation of ventricular tachycardia with radiofrequency currents, with special reference to the termination and minor morphologic change of reinduced ventricular tachycardia
4. Treatment of ventricular-tachycardia by transcatheter radiofrequency ablation in patients with ischemic-heart-disease
5. Radiofrequency catheter ablation for control of frequent ventricular tachycardia with healed myocardial infarction
6. Catheter ablation of ventricular tachycardia in 136 patients with coronary artery disease: Results and long-term follow-up
7. Ventricular tachycardia: Pathophysiology and radiofrequency catheter ablation
8. Catheter ablation of ventricular tachycardia
9. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease
10. Surgery for ventricular tachyarrhythmia based on fragmentation mapping in sinus rhythm alone
11. Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease
12. Use of transient entrainment during ventricular-tachycardia to localize a critical area in the reentry circuit for ablation
13. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping
14. Endocardial mapping of ventricular-tachycardia in the intact human ventricle - Evidence for reentrant mechanisms
15. Endocardial mapping of ventricular-tachycardia in the intact human ventricle. 3. Evidence of multiuse reentry with spontaneous and induced block in portions of reentrant path complex
16. Relation of pace mapping QRS configuration and conduction delay to ventricular tachycardia reentry circuits in human infarct scars
17. Resetting and transient entrainment of ventricular-tachycardia
18. Comparison of effective and ineffective target sites that demonstrate concealed entrainment in patients with coronary artery disease undergoing radiofrequency ablation of ventricular tachycardia
19. Significance of fragmented ventricular electrograms observed using intracardiac recording techniques in man
20. Catheter ablation of ventricular tachycardia after myocardial infarction: Relation of endocardial sinus rhythm late potentials to the reentry circuit
21. Fractionated endocardial electrograms are associated with slow conduction in humans - Evidence from pace-mapping
22. Electrocardiographic features of septal location of right ventricular outflow tract tachycardia
23. Differences in QRS configuration during unipolar pacing from adjacent sites: Implications for the spatial resolution of pace-mapping
24. Catheter ablation of the mitral isthmus for ventricular tachycardia associated with inferior infarction
25. Effect of recording site on postpacing interval measurement during catheter mapping and entrainment of postinfarction ventricular tachycardia
26. Termination of ventricular-tachycardia with epicardial laser photocoagulation - A clinical comparison with patients undergoing successful endocardial photocoagulation alone
27. Temperature-guided radiofrequency catheter ablation with very large distal electrodes
28. A prospective evaluation of catheter ablation of ventricular tachycardia as adjuvant therapy in patients with coronary artery disease and an implantable cardioverter-defibrillator